Halozyme Therapeutics shares owned by Mackenzie Financial
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Mackenzie Financial
from 13F filings
Historical chart of Mackenzie Financial investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Mackenzie Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.6M | 35k | 73.34 |
| 2025-06-30 | $6.2M | 118k | 52.02 |
| 2025-03-31 | $5.5M | 86k | 63.81 |
| 2024-12-31 | $816k | 17k | 46.90 |
| 2024-09-30 | $1.1M | 19k | 57.24 |
| 2024-06-30 | $774k | 15k | 52.36 |
| 2024-03-31 | $423k | 10k | 40.68 |
| 2023-12-31 | $378k | 10k | 36.96 |
| 2023-09-30 | $385k | 10k | 37.65 |
| 2023-06-30 | $377k | 10k | 36.88 |
| 2023-03-31 | $487k | 13k | 38.19 |
| 2022-12-31 | $760k | 13k | 56.90 |
| 2022-09-30 | $449k | 11k | 39.52 |
| 2022-06-30 | $2.7M | 62k | 44.00 |
| 2022-03-31 | $3.1M | 77k | 39.88 |
| 2021-12-31 | $3.2M | 81k | 40.21 |
| 2021-09-30 | $3.3M | 81k | 40.68 |
| 2021-06-30 | $1.2M | 26k | 45.43 |
| 2021-03-31 | $903k | 22k | 41.68 |
| 2020-09-30 | $450k | 17k | 26.29 |
| 2020-06-30 | $749k | 28k | 26.81 |
| 2020-03-31 | $756k | 42k | 17.99 |
| 2019-12-31 | $209k | 12k | 17.70 |
| 2019-06-30 | $289k | 17k | 17.18 |
| 2019-03-31 | $271k | 17k | 16.11 |